Wolfgang Klietmann

From Wikipedia, the free encyclopedia

Dr. Wolfgang Klietmann is a clinical pathologist and medical microbiologist and serves at Harvard Medical School faculty as an appointed Lecturer on Pathology. He heads an international healthcare consulting company, as well as an international business relocation firm.

Previously, Klietmann held a staff member position at the Department of Pathology at the Massachusetts General Hospital.

Prior to his immigration to the United States in 1992, Klietmann founded and was President and Physician-in-Chief of a major Institute of Laboratory Medicine in Germany which he built into a peerless institution in its scientific standing and innovative diagnostic reputation among private laboratories in Germany. The company was bought out by the pharmaceutical industry.

Klietmann has received executive business education in the Owner-President Management Program (OPM12) at Harvard Business School. He received his medical education at the University of Freiburg (Germany), and at the Sorbonne and the University of Paris Medical School (France). He performed postdoctoral research work at The Wistar Institute at the University of Pennsylvania. For five years, Klietmann headed a research group at the Max-Planck-Institute for Virus Research in Tübingen (Germany) and served on the medical faculty of the University of Tübingen until receiving his academic appointment at Harvard Medical School.

A prolific author and guest lecturer with over 200 publications and presentations delivered to audiences across the globe, the cornerstone of Klietmann’s career has centered on infectious diseases and bringing together individuals and organizations to share information, technology and resources. His work in Biodefense includes a collaboration with MIT in a project for the Department of Defense. He serves as Vice President on the Board of Directors of the Harvard Business School Health Industry Alumni Association and organized as co-chairman several major conferences held on the campus of Harvard Business School. His memberships in several scientific societies include a Fellow of the College of American Pathologists.